A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

NCT06132126 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Type 2 Diabetes Mellitus

Interventions

DRUG: LY3938577
DRUG: Placebo
DRUG: Insulin degludec

Sponsor

Eli Lilly and Company